Hepatitis C virus infection, inflammatory myopathy, and pulmonary fibrosis: Are they related?

Journal of Clinical Rheumatology

Volumn 8, Issue 1, 2002, Pages 44-49

  Agha, Bilal ^a   Rasheed, Mehmoodur ^a   Kenyon, Lawrence ^a   Jimenez, Sergio A ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Hepatitis C virus; Inflammatory myopathy; Interstitial lung disease

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LUNG FIBROSIS; MALE; MYOPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 0036167751     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200202000-00010     Document Type: Article

References (38)

1. Polymyositis and dermatomyositis: First of two parts
2. Inflammatory, diseases of muscle and other myopathies
3. Inflammatory and metabolic diseases of muscle
4. Idiopathic inflammatory diseases of muscles
5. Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis
6. A new approach to the classification of idiopathic inflammatory myopathy. Myositis specific autoantibodies define useful homogenous patient groups
7. Mechanisms of inflammation and histopathology in inflammatory myopathy
8. Etiology and pathogenesis of inflammatory muscle disease
9. Hepatitis C. A multifaceted disease: Review of extrahepatic manifestations
10. Musculoskeletal symptoms in patients with hepatitis C
11. Arthritis and hepatitis
12. Clinicians guide to hepatitis C
13. Hepatitis C virus infection and autoimmunity
14. Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications
15. Coxsackie B neutralization titres in polymyositis/dermatomyositis
16. Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis
17. Myopathy with viral-like structures
18. Myositis autoantibody inhibits histidyl-tRNA synthetase: A model for autoimmunity
19. Experimental models of inflammatory myopathies
20. Inclusion-body myositis: Clinicopathological studies and isolation of an adenovirus type 2 from muscle biopsy specimen
21. Inclusion body myositis: The mumps virus hypothesis
22. Polymyositis associated with AIDS retrovirus
23. HTLV-1 and polymyositis in Jamaica
24. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients
25. Dermatomyositis following infection with hepatitis C virus
26. Clinical characteristics and muscle histopathology in polymyositis with positive anti-hepatitis C antibody
27. Polymyositis, pulmonary fibrosis, and hepatitis C
28. Dermatomyositis, hepatocarcinoma, and hepatitis C: Comment on the article by Weidensaul et al
29. Hepatitis C and inclusion body myositis
30. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C
31. Hepatitis C infection and polymyosifis
32. Symptomatic myopathy in hepatitis C infection without interferon therapy
33. Inflammatory myopathy associated with hepatitis C virus infection: A report of four cases
34. Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C infection
35. Inflammatory myopathy and hepatitis C virus infection
36. Hepatitis C and rheumatic diseases
37. Idiopathic pulmonary fibrosis and hepatitis C virus infection
38. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus